Antiplatelet therapy - Part II

S. H. Goodnight, B. M. Coull, J. H. McAnulty, L. M. Taylor

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


We summarize current information about aspirin and other antiplatelet drugs in patients with cardiac and vascular disease. For each indication, we briefly summarize the rationale for the use of antiplatelet therapy and describe the findings of relevant clinical trials. We propose recommendations for the use of these agents in clinical practice. In Part 2, we discuss the use of antiplatelet agents in coronary angioplasty, atrial fibrillation, artificial cardiac valves, stroke, and peripheral vascular disease. In Part 1, we reviewed the use of antiplatelet therapy for the primary and secondary prevention of myocardial infarction, in conjunction with coronary thrombolysis, in patients with unstable and chronic stable angina, and following coronary artery-saphenous vein bypass grafting.

Original languageEnglish (US)
Pages (from-to)506-514
Number of pages9
JournalWestern Journal of Medicine
Issue number5
StatePublished - 1993

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Antiplatelet therapy - Part II'. Together they form a unique fingerprint.

Cite this